“…Pterostilbene has various clinical applications (Estrela et al 2013;McCormack, McFadden 2013). In addition to pterostilbene, other secondary metabolites such as epicatechin (Adinarayana, Syamasundar 1982;Sheehan et al 1983;Chakravarthy, Gode 1985), pterocarpol Rao et al 1984;Maurya et al 1985), pterosupin (Dama et al 1982;Jahromi, Ray 1993;Manickam et al 1997), pterocarposide (Handa et al 2000;Maurya et al 2004;Achari et al 2012;Mishra et al 2013) and marsuposides have also been discovered (Grover et al 2004;Maurya et al 2004;Gupta, Gupta 2009;Joshi et al 2012;Mishra et al 2013). Conventional uses, phytochemical extraction techniques, chemical constituents, pharmacological activity and commercial significance of P. marsupium have already been reviewed (Devgun et al 2009;Badkhane et al 2010;Hari, Gaikwad 2011), but no systematic review exists on the in vitro biotechnology of this species.…”